The Clinical Trials Program in the Mass General Department of Radiology provides access to the expertise and technology of a premiere academic radiology department.

It offers the expertise of over 100 world-renowned radiologists and 200 PhDs to provide blinded reads and extensive consultative services for tclinical trials.

With over 20 years of clinical trial experience, our radiologists understand the unique needs of CROs and pharmaceutical companies and are well equipped to handle even the most challenging of trials.

Learn about our therapeutic expertise

What We Do

Current Studies

  • Prostate Cancer using RECIST 1.1
  • Lymphoma using Cheson
  • Chronic Lymphocytic Leukemia using iwCLL 2008
  • Solid Tumors using RECIST 1.1 + volumes + irRC
  • Cardiac Safety using LVEF
  • Gout using RAMRIS
  • Glioblastoma Multiforme progression of disease
  • Non-Small Cell Lung Cancer using RECIST 1.1
  • Head & Neck Cancer using RECIST 1.1
  • Multiple Sclerosis using T1/T2 Counts and Brain Volume
  • Breast Cancer using modified RECIST
  • Non-Hodgkin's Lymophoma using Cheson
  • Melanoma using LVEF & Wall Motion
  • Metastatic Melanoma using RECIST 1.1
  • Mantle Cell Lymphoma using Cheson
  • Ovarian Cancer using RECIST
  • Traumatic Brain Injury using Marshall Scoring
  • Rheumatoid Arthritis using Sharp & Van der Heijde Scoring
  • Breast Cancer using RECIST 1.1